Bağışıklama günümüzde, her yıl 2-3 milyon arasında difteri, tetanoz, boğmaca ve kızamık ölümlerini önlemektedir. Bu yönüyle, en başarılı ve maliyet etkili halk sağlığı müdahalelerinden biri olarak kabul edilmektedir. Bağışıklamanın pek çok faydası bulunmaktadır. Üstelik bu faydalar, hem bağışıklanan kişiye hem de toplumun diğer kesimlerine yansımaktadır. Bu faydalardan birisi bağışıklamanın oluşturduğu dışsallıklardır. Dışsallık, ekonomide olduğu gibi sağlık ekonomisinde de önemli bir kavramdır. Koruyucu sağlık müdahalelerinden biri olarak bağışıklamanın sağladığı katkıların yani dışsallıkların toplum sağlığına ve sağlık ekonomisine katkısı yadsınamaz derecede büyüktür. Bu çalışmada, bağışıklamanın dışsallığına sağlık ekonomisi açısından bir perspektif sunulması amaçlanmıştır. Bu kapsamda, çalışmada bağışıklama kavramı açıklanmış ve dünya genelinde bağışıklama ile ilgili verilere yer verilmiştir. Bağışıklamanın pozitif dışsallığının yanı sıra negatif dışsallıklarının olduğu vurgulanmış, dışsallık ile yakından ilişki olan bedavacılık sorunu da bağışıklama konusu içinde ele alınmıştır. Ardından, topluma sağlanan dışsallıkların bireysel anlamda içselleştirilmesinin yöntemlerinden biri olan sübvansiyonların bağışıklamada nasıl kullanılabileceğine değinilmiştir. Türkçe literatürde, bağışıklama ve dışsallık kavramlarını bir arada ele alan bir çalışmanın bulunmaması sebebiyle bu çalışmanın literatüre katkı sağlayacağı düşünülmektedir.
Anahtar Kelimeler: Bağışıklama; aşılama; dışsallık
Immunization now prevents 2-3 million diphtheria, tetanus, pertussis and measles deaths every year. In this regard, it is considered one of the most successful and cost effective public health interventions. Immunization has many benefits. Moreover, these benefits are reflected both in the immunized individual and in other segments of society. One of these benefits is the externalities that immunity creates. Externality is an important concept in the health economy as it is in the economy. As one of the preventive health interventions, the contribution of immunization, that is, the externalities, is inevitably greater than the contribution to public health and the health economy. The aim of this study is to provide a perspective on the externality of immunization in terms of health economics. In this context, the concept of immunization in the study is explained and the immunization related data are given worldwide. In addition to the positive externality of immunization, it was emphasized that there are negative externalities, and the problem of free agency, which is closely related to externality, is also handled in immunization. Later, it was emphasized that negative externality as well as positive externality of immunization. In addition, the issue of free-ridership, which is closely related to externality, has been addressed in the context of immunization. Then, it is mentioned how subsidies, which are one of the methods of internalizing of collectivized externalities, can be used in immunization. It is thought that this study will contribute to the literature because there is no study in Turkish literature that combines the concepts of immunization and externality.
Keywords: Immunization; vaccination; externality
- Cohen ML. Changing patterns of infectious diseases. Nature. 2000 406(6797):762-7. [Crossref] [PubMed]
- Arvas A. [The importance of vaccination in children]. Klinik Gelişim. 2012;25:1-3.
- John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000;16(7):601-6. [Crossref]
- Henderson RH. Vaccination: success and challenges. In: Cutts FT, Smith PG, eds. Vaccination and World Health. 1st ed. Chichester, England: John Wiley; 1995. p.316.
- Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the infections diseases Society of America. Clin Infect Dis. 2009;49(6):817-40. [Crossref] [PubMed]
- Alpay Y, Ağalar C. [Adult immunization]. Flora. 2016;21(3):95-104.
- Infectious Diseases Society of America. Actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America. Clin Infect Dis. 2007;44(12):e104-8. [Crossref ] [PubMed]
- U.S. Centers for Disease Control and Prevention (CDC). How your child care program can support immunization. CDC; 2017. p.37.
- Vo NX, Vo TQ, Nguyen HTS, Van Ha T. The economic evaluation in vaccines-a systematic review in Vietnam Situation. Sys Rev Pharm. 2018;9(1):111-2. [Crossref ]
- Yamashiro H, Cutcliffe N, Dobson S, Fisman D, Gold R. The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective. Can J Infect Dis Med Microbiol. 2015;26(4):183-90. [Crossref] [PubMed] [PMC]
- Shen AK, Spinner JR, Salmon DA, Gellin BG. Strengthening the U.S. vaccine and immunization enterprise: the role of the National Vaccine Advisory Committee. Public Health Rep. 2011;126(1):4-8. [Crossref] [PubMed] [PMC]
- The World Bank. World Development Report 1993. 1st ed. New York: Oxford University Press; 1993. p.9. [Crossref ]
- Sharma B, Mahajan H, Velhal GD. Immunization coverage: role of sociodemographic variables. Adv Prev Med. 2013;2013:607935. [Crossref] [PubMed] [PMC]
- Nohynek H, Wichmann O, D?Ancona F. National Advisory Groups and their role in immunization policy-making processes in European countries. Clin Microbiol Infect. 2013;19(12):1096-105. [Crossref ] [PubMed]
- Brenzel L, Wolfson LJ, Fox-Rushby J, Miller M, Halsey NA. Vaccine-preventable diseases. Drug/Vaccines/Product Development. Washington, DC: The World Bank; 2006. p.389-412.
- Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health. 2018;12(1):878. [Crossref] [PubMed] [PMC]
- World Health Organization (WHO). Weekly epidemiologica record Relevé épidémiologiwue hebdomadaire. WHO 2013;88:413-28. Access: 27.09.2018. [Link ]
- Bärnighausen T, Bloom DE, Cafiero ET, O?Brien JC. Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil. Semin Immunol. 2013;25(2):104-13. [Crossref ] [PubMed]
- Bärnighausen T, Bloom DE, Canning D, Friedman A, Levine OS, O?Brien J, et al. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. Vaccine. 2011;29(13): 2371-80. [Crossref ] [ PubMed]
- Diekema DS. Responding to parental refusals of immunization of children. Pediatrics. 2005;115(5):1428-31. [Crossref ] [ PubMed]
- UNICEF. Communication handbook for polio eradication and routine EPI. 1st ed. New York: UNICEF and WHO; 2000. p.97.
- UNICEF/WHO, 2017. 1 in 10 infants worldwide did not receive any vaccinations in 2016. Access:09.06.2018. [Link ]
- WHO (2018). Immunization. Access: 11.06. 2018. [Link ]
- Jit M, Mibei W. Discounting in the evaluation of the cost-effectiveness of a vaccination programme: a critical review. Vaccine. 2015;33(32):3788-94. [Crossref ] [ PubMed]
- Rat-Aspert O, Fourichon C. Modelling collective effectiveness of voluntary vaccination with and without incentives. Prev Vet Med. 2010;93(4):265-75. [Crossref ] [PubMed]
- Carande-Kulis VG, Getzen TE, Thacker SB. Public goods and externalities: a research agenda for public health economics. J Public Health Manag Pract. 2007;13(2):227-32. [Crossref ] [PubMed]
- Bakırtaş İ. [The effectiveness of regulatory taxes and subsidies in the internalization of the problem of externalities: an analytical approach]. Dumlupınar Üniversitesi Sosyal Bilimler Dergisi. 2015;7:1-19.
- Kremer M, Snyder CM, Williams H. Which diseases generate the largest epidemiological externalities? In Communication at the AEA 2009 Annual Meeting; 2008.
- Althouse BM, Bergstrom TC, Bergstrom CT. Evolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseases. Proc Natl Acad Sci U S A. 2010;107 Suppl 1:1696-701.
- Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics. 2008;26(3):191-215. [Crossref] [PubMed]
- Organisation for Economic Co-operation and Development (OECD). Child vaccination rates (indicator). Doi: 10.1787/b23c7d13-en. Access 10.06.2018. [Crossref ]
- Chen F, Toxvaerd F. The economics of vaccination. J Theor Biol. 2014;363:105-17. [Cross ref] [PubMed]
- Shim E, Chapman GB, Townsend JP, Galvani AP. The influence of altruism on influenza vaccination decisions. J R Soc Interface. 2012;9(74):2234-43. [Crossref] [PubMed] [PMC]
- Fisman DN, Laupland KB. The sounds of silence: public goods, externalities, and the value of infectious disease control programs. Can J Infect Dis Med Microbiol. 2009;20(2):39-41. [Crossref ] [PubMed]
- Talamàs E, Vohra R. Go big or go home: a free and perfectly safe but only partially effective vaccine can make everyone worse off. PIER Working Paper No. 18-006. 2018;20. [Crossref]
- Ozawa S, Portnoy A, Getaneh H, Clark S, Knoll M, Bishai D, et al. Modeling the economic burden of adult vaccine-preventable diseases in the United States. Health Aff (Millwood). 2016;35(11):2124-32. [Crossref] [PubMed]
- Shi X. Information disclosure and vaccination externalities. Int J Econ Theory. 2013;9(3): 229-43. [Crossref ]
- Couzin-Frankel J. What role for antiviral drugs?. Science. 2009; 324(5928):705. [Crossref] [PubMed]
- Shi Y. Epidemic outbreak and information disclosure. Mimeo; University of North Carolina; 2007.
- World Health Organization (WHO). Current WHO phase of pandemic alert for pandemic (H1N1) 2009. Access: 27.09.2018. [Link ]
- Chen F. Voluntary vaccinations and vaccine shortages: a theoretical analysis. J Theor Biol. 2018;446:19-32. [Crossref ] [ PubMed]
- Buttenheim AM, Asch DA. Making vaccine refusal less of a free ride. Hum Vaccin Immunother. 2013;9(12):2674-5. [Crossref] [PubMed] [PMC]
- Bauch CT, Earn DJ. Vaccination and the theory of games. Proc Natl Acad Sci U S A. 2004;101(36):13391-4. [Crossref] [PubMed] [PMC]
- Hershey JC, Asch DA, Thumasathit T, Meszaros J, Waters VV. The roles of altruism, free riding, and bandwagoning in vaccination decisions. Organ Behav Hum. 1994;59:177-87. [Crossref ]
- Hornik R, Jacobsohn L, Orwin R, Piesse A, Kalton G. Effects of the national youth antidrug media campaign on youths. Am J Public Health. 2008;98(12):2229-36. [Crossref] [PubMed] [PMC]
- Akalın G. Kamu Ekonomisi. 1. Baskı. Ankara: Akçağ Yayınları; 2000.
- Bailey SJ. Public Sector Economics: Theory, Policy and Practice. 1st ed. Chatham: Mackays of Chatham PLc; 1995. p.406. [Crossref ]
- Köktaş AM. Sağlık Ekonomisi. Ankara: 657 Yayınevi; 2014.
- Nath S. A Perspective of Welfare Economics. 1st ed. London: Macmillan; 1973. p.66. [Crossref ]
.: Process List